Journament

Keyword Connections - lung neoplasms Keywords

Connection Type	Connection
Journals	European radiology zhonghua yi xue za zhi zhonghua yu fang yi xue za zhi [chinese journal of preventive medicine] journal for immunotherapy of cancer american journal of respiratory and critical care medicine journal of biomedical physics & engineering
Research Groups	No Research Group Connected
Bibliographies	[1] [Analysis of sugammadex for antagonistic neuromuscular block in patients with radical resection of lung cancer under thoracoscope]. [2] Dynamic MLC Tracking Using 4D Lung Tumor Motion Modelling and EPID Feedback. [3] Diesel Engine Exhaust Exposure, Smoking, and Lung Cancer Subtype Risks: A Pooled Exposure-response Analysis of 14 Case-control Studies. [4] COVID-19 and lung cancer: risks, mechanisms and treatment interactions. [5] Immune-related pneumonitis associated with immune checkpoint inhibitors in lung cancer: a network meta-analysis. [6] [The development and validation of risk prediction model for lung cancer: a systematic review]. [7] clinical significance of detection of serum values of neuron specific enolase  before and after treatment for small cell lung cancer [8] mechanism of trim24 to regulate resistance of gefitinib in nsclc cells [9] mechanism of c-met in non-small cell lung cancer and its treatment and testing [10] mutational analysis of hogg1 gene promoter in patients with non-small cell lung cancer [11] surgical treatment of lung cancer combined with interstitial lung disease [12] prospective analysis on survival outcomes of nonsmall cell lung cancer stages over iiib treated with hangam-dan [13] the correlation between the up-regulation of hsp90  and drug resistance to cisplatin in lung cancer cell line [14] surgical treatment for non-small cell lung cancer patients with synchronous solitary brain metastasis [15] distribution and mrna expression of bambi in non-small-cell lung cancer [16] hormonal replacement therapy and the risk of lung cancer in women: an adaptive meta-analysis of cohort studies [17] expression and significance of p120ctn isoforms in lung squamous cell carcinomas [18] fibrobroncoscopia en el cáncer de pulmón [19] analysis of the factors associated with abnormal coagulation and prognosis in patients with non-small cell lung cancer [20] role of nkg2d-expressing nk cells and smica in immune surveillance of advanced lung cancer [21] clinical observation of erlotnib in the treatment of non-small cell lung cancer with multimetastases in elderly patients [22] relationship between bim gene polymorphism and therapeutic efficacy in the  retreatment of advanced non-small cell lung cancer with tyrosine kinase inhibitor [23] advance of lung cancer screening with low-dose spiral ct [24] achados de fibrobroncoscopia em pacientes com diagnóstico de neoplasia pulmonar fiberoptic bronchoscopy findings in patients diagnosed with lung cancer [25] relationship between the expression of prdm14 in non-small cell lung cancer and the clinicopathologic characteristics [26] dosimetry: which dose for screening, diagnosis and follow-up ? [27] high expression of dnmt1 was correlated with beta-catenin accumulation and malignant phynotype of lung squamous cell carcinoma and adenocarcinoma [28] analysis of subclassification by size and survival-associated factors of stageⅠnon-small cell lung cancer [29] effect of bufalin on proliferation and apoptosis of human non-small cell lung cancer a549 cell [30] detecção de micrometástases em câncer de pulmão não-pequenas células estádio pn0: um método alternativo combinando imunohistoquímica e análise em microsséries detection of micrometastases in pn0 non-small cell lung cancer: an alternative method combining tissue microarray and immunohistochemistry [31] clinical research of perioperative serum vegf and mmp-9 levels in patients with non-small cell lung cancer [32] effect of informing the diagnosis on depressive state in patients with non-small cell lung cancer of stage Ⅲ [33] role of the expression level of nrf2 in predicting response of egfr-tkis  in lung adenocarcinoma patients with egfr gene mutations [34] one case of multiple inflammatory pseudotumor in both lungs [35] the comparative study of lymph node dissection by video-assisted thoracoscopic surgery (vats) and conventional lateral incision surgery [36] opinions, practice patterns, and perceived barriers to lung cancer screening among attending and resident primary care physicians [37] expression of carbonic anhydrase ix in nsclc and its relationship with vegf and ki67 expression [38] advance of second-line chemotherapy in advanced non-small cell lung cancer [39] expression and significance of snail and claudin-3 in non-small cell lung cancer [40] expressions of c-cbl, cbl-b and egfr and its role of prognosis in nsclc [41] the advances of lymphangiogenesis in lung cancer [42] the clinical significance of β-arrestin 2 expression in the serum of  non-small cell lung cancer patients [43] endoscopic argon plasma coagulation for the management of solid, centrally located lung cancer [44] the expression status of 11 genes, located at the commonly deleted region 3p21.3, in non-small cell lung cancer [45] analysis of the relationship between the response after the first-line chemotherapy and the survival in the advanced non-small cell lung cancer [46] application of epidermal growth factor receptor tyrosine kinase inhibitor as the first-line therapy in patients with advanced non-small cell lung cancer [47] clinical characteristics and prognostic factors of lung adenosquamous carcinoma  in seer database between 2010 and 2015 [48] lung cancer therapy treatments in the elderly [49] clinical analysis of icotinib on beneficiary of  advanced non-small cell lung cancer with egfr common mutation [50] mir-614 inhibited lung cancer cell invasion and proliferation via targeting psa [51] analysis of advanced non-small cell lung cancer course during high dose antiestrogen therapy use in complex chemoradiotherapy treatment of patients [52] expression of dll4 and vegf in lung adenocarcinoma and their relationship with angiogenesis in tumor [53] propensity score matching analysis of vats lobectomy and sublobar resection for stage i lung adenocarcinoma [54] expression and significance of clusterin in anip973/nvb cell lines [55] surgery for pulmonary multiple ground glass opacities [56] advances in antiangiogenic treatment of advanced non-squamous non-small cell lung cancer in 2017 asco and wclc [57] analysis of the efficacy and survival of third-line treatment  in advanced non-small cell lung cancer [58] a preliminary study on the origin of human lung adenocarcinoma stem cells from lung bonchioalveolar stem cells [59] primary pulmonary mucinous (colloid) adenocarcinoma that arose in the cavernomyoplasty area in a patient with tuberculosis: a rare case report [60] clinical analysis of lung cancer patients younger than 30 years [61] diagnotic value of the combined determination of telomerase activity in induced sputum, pleural effusion and fiberobronchoscopic biopsy samples in lung cancer [62] examining the association between statins and lung cancer incidence in patients with type 2 diabetes mellitus [63] the value of mediastinoscopy in the staging of lung cancer with clinical n2 disease [64] research progress of matrix metalloproteinase 12 in non-small cell lung cancer [65] effects of mvp regimen on operation and cancer tisswes of lung cancer patients [66] gefitinib for non-small cell lung cancer: a meta analysis [67] study on effects and mechanisms of phytochemicals in vegetables and fruits  in preventing and treating lung cancer [68] prokaryotic expression and purification of human tle1 n-terminal q domain fragment and production of its polyclonal antibody [69] CT-based radiomics for prediction of histologic subtype and metastatic disease in primary malignant lung neoplasms.